Imatinib-d8 (C007B-196038)

Application：Imatinib-d8 is a deuterated tyrosine kinase inhibitor. It is a COVID19-related research product. Specification: 98%，98atom%D Molecular Formula: C29H23D8N7O Molecular Weight: 501.65 PubChem CID: 25235773 Isomeric SMILES: [2H]C1(C(N(C(C(N1C)([2H])[2H])([2H])[2H])CC2=CC=C(C=C2)C(=O)NC3=CC(=C(C=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5)([2H])[2H])[2H] Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/I341912-SCI_2e9841dde26aa66bc247361eb2f9c666.pdf

UPC:

51112005

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

I341912-1mg

CAS:

1092942-82-9

Product Size:

1mg

Hazard Statement Codes:

H302

Precautionary Statement Codes:

P264:P270